Literature DB >> 3263440

Antiviral immunity induced by recombinant nucleoprotein of influenza A virus. I. Characteristics and cross-reactivity of T cell responses.

J P Tite1, S M Russell, G Dougan, D O'Callaghan, I Jones, G Brownlee, F Y Liew.   

Abstract

The gene for the nucleoprotein of the A/NT/60/68 influenza virus was expressed in bacteria and the recombinant protein purified. Lymph node cells from mice immunized with recombinant nucleoprotein proliferated in response to in vitro stimulation with a range of type A influenza viruses. Proliferation was inhibited by mAb to CD4 and class II MHC gene products. IFN-gamma was produced and type-specific CTL were generated in stimulated cultures of immune lymph node cells. These CTL were CD4+ and restricted to class II MHC gene products. Immunization with recombinant nucleoprotein generated Th cells in vivo as measured by the ability to generate an accelerated response to hemagglutinin after challenge with inactivated virus. The results are discussed with reference to a cross-reactive vaccine against influenza.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263440

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

2.  Construction and characterization in vivo of Bordetella pertussis aroA mutants.

Authors:  M Roberts; D Maskell; P Novotny; G Dougan
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

3.  Control by H-2 genes of the Th1 response induced against a foreign antigen expressed by attenuated Salmonella typhimurium.

Authors:  R Lo-Man; P Martineau; E Dériaud; S M Newton; M Jehanno; J M Clément; C Fayolle; M Hofnung; C D Leclerc
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection.

Authors:  J P Tite; C Hughes-Jenkins; D O'Callaghan; G Dougan; S M Russell; X M Gao; F Y Liew
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

5.  An ELISA for detection of antibodies against influenza A nucleoprotein in humans and various animal species.

Authors:  G F de Boer; W Back; A D Osterhaus
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

7.  Isolation of orally attenuated Salmonella typhimurium following TnphoA mutagenesis.

Authors:  I Miller; D Maskell; C Hormaeche; K Johnson; D Pickard; G Dougan
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

8.  Antigenic sequences of poliovirus recognized by T cells: serotype-specific epitopes on VP1 and VP3 and cross-reactive epitopes on VP4 defined by using CD4+ T-cell clones.

Authors:  B P Mahon; K Katrak; K H Mills
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Genetic control of antibody responses induced against an antigen delivered by recombinant attenuated Salmonella typhimurium.

Authors:  C Fayolle; D O'Callaghan; P Martineau; A Charbit; J M Clément; M Hofnung; C Leclerc
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis.

Authors:  R Strugnell; G Dougan; S Chatfield; I Charles; N Fairweather; J Tite; J L Li; J Beesley; M Roberts
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.